Global Perspectives in Gynecologic Malignancies
Expert perspectives and strategic insights on the latest therapeutic developments in gynecologic malignancies.
Faculty Chair
Robert Coleman, MD
University of Texas, MD Anderson Cancer Center, Houston, TX
FACULTY MEMBERS
John Chan, MD
UCSF Helen Diller Family Comprehensive Cancer Center, CA, US
Christina Fotopoulou, MD, PhD
Imperial College London Healthcare Trust, London, UK
Jonathan Ledermann, MD
UCL Cancer Institute, London, UK
Ursula Matulonis, MD
Dana-Farber Cancer Institute, MA, US
Bradley Monk, MD
Biltmore Cancer Center, AZ, US
Kathleen Moore, MD
OU Health, OK, US
David O’Malley, MD
The Ohio State University College of Medicine, OH, US
Leslie M. Randall, MD
UCI Health, CA, US
Brian Slomovitz, MD
University of Miami Hospital, FL, US
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Early Stage Ovarian Cancer
- First-Line Treatments and Maintenance Therapy for Advanced Ovarian Cancer
- Treatment Strategies for Relapsed Ovarian Cancer
- Current Treatment and Future Directions for Advanced Endometrial Cancer
- Early Stage Cervical Cancer
- Advanced Cervical Cancer: Current and Future Treatment
